Peginterferon beta-1a Subcutaneous and Sandostatin LAR
Determining the interaction of Peginterferon beta-1a Subcutaneous and Sandostatin LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: peginterferon beta-1a
Brand name: Plegridy, Plegridy Pen, Plegridy Pen Starter Pack, Plegridy Starter Pack
Synonyms: Peginterferon beta-1a, Peginterferon Beta-1a
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Peginterferon beta-1a Subcutaneous-Sandostatin LAR Depot
- Peginterferon beta-1a Subcutaneous-Sandostatin LAR Depot injection
- Peginterferon beta-1a Subcutaneous-Sani-Supp
- Peginterferon beta-1a Subcutaneous-Sani-Supp rectal
- Peginterferon beta-1a Subcutaneous-Sansert
- Peginterferon beta-1a Subcutaneous-Santyl
- Sandostatin LAR-PegIntron
- Sandostatin LAR-Pegloticase
- Sandostatin LAR-Pegloticase Intravenous
- Sandostatin LAR-Pegvaliase
- Sandostatin LAR-Pegvaliase-pqpz
- Sandostatin LAR-Pegvaliase-pqpz Subcutaneous